Hong Jiang is an entrepreneur, investor, researcher, and community builder working at the intersection of biotechnology, longevity, and emerging technologies.
She is CEO of Positivo Biotechnology, where she leads the development of non-viral DNA gene therapies for health and longevity. Previously, she co-founded Aegis Life and has led investments in cancer, HIV, and longevity therapeutics. Her career also spans telecommunications and technology, including work at Bell Labs and the co-founding of several technology companies.
